Paulo Shiroma
Staff Psychiatrist at Minneapolis VA and Assistant Professor of Psychiatry at the University of Minnesota
Data updated
Research Footprint
Paulo Shiroma appears in 6 tracked papers (2018–2022), most studied alongside Ketamine and Placebo, across Depressive Disorders, PTSD and Anxiety Disorders.
Most-cited paper: Efficacy, Safety, and Durability of Repeated Ketamine Infusions for Comorbid Posttraumatic Stress Disorder and Treatment-Resistant Depression (161 citations).
Frequent co-authors: Chadi Abdallah, John Krystal and Lauren Averill.
Background & Research
Paulo Shiroma, MD, is a staff psychiatrist at the Minneapolis VA and an assistant professor of psychiatry at the University of Minnesota. His research has focused on ketamine and refractory depression/PTSD, and he has been conducting studies of repeated ketamine for these conditions at the Minneapolis VA since 2013. He is the author of multiple ketamine clinical trial and review papers in depression and PTSD.
Key Impact
He is a leading clinical researcher on ketamine for treatment-resistant depression and PTSD, including repeated infusion protocols and cognitive effects in veterans.
Collaboration Network
18 collaborators· click a node to visit their profile
Full network →Compounds
Topics
Top Collaborators
Affiliations
Institutions, companies, and organisations Paulo Shiroma is associated with.